According to Kezar Life Sciences's latest financial reports the company's current earnings (TTM) are -HK$0.77 B. In 2023 the company made an earning of -HK$0.8 B a decrease over its 2022 earnings that were of -HK$0.54 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.